Table 1.
Clinical and demographic dataa
| NC (n = 46) | MCI (n= 23) | AD (n= 12) | |
|---|---|---|---|
| Age (y) | 73.8 (7.7) | 74.3 (8.5) | 75.8 (9.9) |
| Education (y) | 16.3 (2.1) | 15.7 (2.7) | 15.5 (2.4) |
| Gender (% male) | 34.8% | 56.5% | 58.3% |
| ApoE4 genotype (%)b | 28.3% | 47.8% | 50.0% |
| Vascular Risk (%)c | 21.7% | 34.8% | 25.0% |
| Taking BP Med (%) | 50.0% | 56.5% | 58.3% |
| DRS total score | 141.8 (1.8) | 136.7 (4.4) | 123.0 (7.6) |
| MAP (mmHg) | 92.2(9.1) | 95.2(11.7) | 100.4 (11.3)* |
a
Mean or % (Standard Deviation)
b
ApoE4 genotype (%), percent with one or more copies of ApoE4 allele; cVascular Risk (%), percent with one or more vascular risk factors. NC, normal control; MCI, mild cognitive impairment; AD, Alzheimer's disease; BP, blood pressure; DRS, Mattis Dementia Rating Scale; MAP, mean arterial pressure.
*
p < 0.05 for AD versus NC.